Moderna

About:

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Website: http://www.modernatx.com

Twitter/X: moderna_tx

Top Investors: RA Capital Management, Alexandria Venture Investments, AstraZeneca, Fidelity, Invus

Description:

Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.

Total Funding Amount:

$3.91B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)modernatx.com

Hub Tags:

Exited Unicorn

Founders:

Derrick Rossi, Kenneth Chien, Noubar Afeyan, Robert Langer

Number of Employees:

1001-5000

Last Funding Date:

2024-07-02

IPO Status:

Public

© 2025 bioDAO.ai